Independent testing of 1,866 peptide samples from 134 different vendors found purity ranging from 62% to 100%, with quantity accuracy diverging by as much as 10,000%
When combined, these effects may compoundpotentially making early treatment phases more uncomfortable and increasing the risk of medication non-adherence
Most patients notice appetite suppression within the first few days of injection, but visible weight loss on the scale generally emerges between weeks 2 and 8
Wegovy prescribing information states that the drug delays gastric emptying, has been associated with gastrointestinal adverse reactions that are sometimes severe, and is not recommended in patients with severe gastroparesis
Weight loss before pregnancy offers health benefits for both mother and baby
The peptide can be administered subcutaneously, with some researchers using it in the same protocol alongside BPC-157 and TB-500